...
首页> 外文期刊>American journal of respiratory and critical care medicine >Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease A Two-Edged Sword
【24h】

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease A Two-Edged Sword

机译:吸入性糖皮质激素治疗慢性阻塞性肺疾病的两刃剑

获取原文
获取原文并翻译 | 示例

摘要

The field of immunology is constantly expanding, and although focus has slightly turned from T cell- to more B cell-oriented research, new knowledge on unconventional T cells is still garnered. One example of this is the relatively recently discovered MR1-restricted T cells designated "mucosal-associated invariant T" (MAIT) cells (1). Intriguingly, MAIT cells comprise 5 to 10% of the total pool of CD3~+ T cells in peripheral blood. As a result of development of monoclonal antibodies, the CD161~+ MAIT-cell subset has been defined as having an invariant T-cell receptor, designated TCR Vα7.2, that recognizes the MR1 molecule on antigen-presenting cells-for example, B cells.
机译:免疫学的领域正在不断扩大,尽管重点已从T细胞转向B细胞,但非常规T细胞的新知识仍在积累。这方面的一个例子是相对较新发现的MR1限制性T细胞,称为“粘膜相关不变T”(MAIT)细胞(1)。有趣的是,MAIT细胞占外周血CD3 + + T细胞总数的5至10%。作为单克隆抗体开发的结果,CD161〜+ MAIT细胞亚群已被定义为具有不变的T细胞受体,称为TCRVα7.2,可识别抗原呈递细胞上的MR1分子,例如B细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号